World TB Day: Vaccine trial inspires SATVI clinicians to imagine a world without TB

On World TB Day, the University of Cape Town (UCT) shines the spotlight on phase three of a clinical trial led by clinicians at the South African Tuberculosis Vaccine Initiative (SATVI).

The study aims to explore and assess the safety, immunogenicity and efficacy of the novel MTBVAC as a potential TB vaccine alternative to the age-old bacille Calmette-Guerin (BCG), currently administered at birth to protect babies from TB.